Restoring MEG3 function in vitro impaired the tumorigenic abilities of GSCs, evidenced by inhibited cell growth, migration, and colony formation, alongside reduced in vivo tumor growth, thereby attenuating infiltration. The gene discussed is MEG3; the disease is neoplasm.